Kenneth A. Jacobson
Cited by
Cited by
International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors
BB Fredholm, AP IJzerman, KA Jacobson, KN Klotz, J Linden
Pharmacological reviews 53 (4), 527-552, 2001
VI. Nomenclature and classification of purinoceptors
B Fredholm, M Abbracchio, G Burnstock, J Daly, K Harden, K Jacobson, ...
The Journal of Pharmacology and Experimental Therapeutics 46 (2), 143, 1994
Adenosine receptors as therapeutic targets
KA Jacobson, ZG Gao
Nature reviews Drug discovery 5 (3), 247-264, 2006
International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy
MP Abbracchio, G Burnstock, JM Boeynaems, EA Barnard, JL Boyer, ...
Pharmacological reviews 58 (3), 281-341, 2006
International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors—an update
BB Fredholm, AP IJzerman, KA Jacobson, J Linden, CE Müller
Pharmacological reviews 63 (1), 1-34, 2011
Structure of an agonist-bound human A2A adenosine receptor
F Xu, H Wu, V Katritch, GW Han, KA Jacobson, ZG Gao, V Cherezov, ...
Science 332 (6027), 322-327, 2011
UDP acting at P2Y6 receptors is a mediator of microglial phagocytosis
S Koizumi, Y Shigemoto-Mogami, K Nasu-Tada, Y Shinozaki, K Ohsawa, ...
Nature 446 (7139), 1091-1095, 2007
The Concise Guide to PHARMACOLOGY 2019/20: G protein‐coupled receptors
SPH Alexander, A Christopoulos, AP Davenport, E Kelly, A Mathie, ...
British journal of pharmacology 176, S21-S141, 2019
Adenosine receptors: pharmacology, structure-activity relationships, and therapeutic potential
KA Jacobson, PJM Van Galen, M Williams
Journal of medicinal chemistry 35 (3), 407-422, 1992
Coordinated adenine nucleotide phosphohydrolysis and nucleoside signaling in posthypoxic endothelium: role of ectonucleotidases and adenosine A2B receptors
HK Eltzschig, JC Ibla, GT Furuta, MO Leonard, KA Jacobson, K Enjyoji, ...
The Journal of experimental medicine 198 (5), 783-796, 2003
Characterization of the UDP-glucose receptor (re-named here the P2Y14 receptor) adds diversity to the P2Y receptor family
MP Abbracchio, JM Boeynaems, EA Barnard, JL Boyer, C Kennedy, ...
Trends in pharmacological sciences 24 (2), 52-55, 2003
Recent developments in adenosine receptor ligands and their potential as novel drugs
CE Müller, KA Jacobson
Biochimica et Biophysica Acta (BBA)-Biomembranes 1808 (5), 1290-1308, 2011
Towards a revised nomenclature for P1 and P2 receptors
BB Fredholm, MP Abbracchio, G Burnstock, GR Dubyak, TK Harden, ...
Trends in pharmacological sciences 18 (3), 79, 1997
Structure of the human P2Y12 receptor in complex with an antithrombotic drug
K Zhang, J Zhang, ZG Gao, D Zhang, L Zhu, GW Han, SM Moss, ...
Nature 509 (7498), 115-118, 2014
Purine and pyrimidine (P2) receptors as drug targets
KA Jacobson, MF Jarvis, M Williams
Journal of medicinal chemistry 45 (19), 4057-4093, 2002
Adenosine A3 receptors: novel ligands and paradoxical effects
KA Jacobson
Trends in pharmacological sciences 19 (5), 184-191, 1998
Adenosine A3 receptor stimulation and cerebral ischemia
DKJE Von Lubitz, RCS Lin, P Popik, MF Carter, KA Jacobson
European journal of pharmacology 263 (1-2), 59-67, 1994
Adenosine receptor ligands: differences with acute versus chronic treatment
KA Jacobson, DKJE von Lubitz, JW Daly, BB Fredholm
Trends in pharmacological sciences 17 (3), 108-113, 1996
Two disparate ligand-binding sites in the human P2Y1 receptor
D Zhang, ZG Gao, K Zhang, E Kiselev, S Crane, J Wang, S Paoletta, C Yi, ...
Nature 520 (7547), 317-321, 2015
Agonist-bound structure of the human P2Y12 receptor
J Zhang, K Zhang, ZG Gao, S Paoletta, D Zhang, GW Han, T Li, L Ma, ...
Nature 509 (7498), 119-122, 2014
The system can't perform the operation now. Try again later.
Articles 1–20